Home Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission ...
 

Keywords :   


Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission ...

2014-12-24 16:54:20| Biotech - Topix.net

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc , and BioDelivery Sciences International, Inc. announced today that they have submitted a New Drug Application for Buprenorphine HCl Buccal Film to the U.S. Food and Drug Administration . Buprenorphine HCl Buccal Film is under development for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Tags: sciences submission announce pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
04.07Hurricane Beryl Graphics
04.07Hurricane Beryl Public Advisory Number 21A
04.07Summary for Hurricane Beryl (AT2/AL022024)
04.07Atlantic Tropical Weather Outlook
04.07Would having an AI boss be better than your current human one?
04.07Eastern North Pacific Tropical Weather Outlook
03.07Wild ride in feeder cattle markets
03.07PLC accepts rolling submissions for research proposals bolstering federal lands ranching
More »